The capital-sequence view highlights where investment timing is tight, where payback is shortest, and where trim decisions release the most leverage.
| Owner | Audience | Urgency | Payback window | Savings leverage | Headline |
|---|---|---|---|---|---|
| AI operating partner | Board strategy committee | 79 | 88 | 62 | AI is the clearest fund-now lane because it compounds board trust and cross-functional reuse. |
| Identity assurance lead | Risk committee | 73 | 74 | 58 | Identity should be protected because it carries disproportionate board trust for the rest of the control stack. |
| Revenue systems partner | Operating committee | 77 | 84 | 91 | Revenue should be funded where margin recovery is already board-readable, not merely plausible. |
| FinTech diligence lead | Investor diligence committee | 71 | 57 | 49 | FinTech should hold for now because the downside clusters faster than the board proof improves. |
| Quality systems sponsor | Regulated growth committee | 63 | 72 | 44 | Biotech should be protected because the regulated system already reads as one defensible story. |
| Procurement intelligence lead | Go-to-market committee | 81 | 83 | 89 | Procurement is the clearest trim lane because savings are visible without killing the core trust story. |